Alain Hovnanian

chef d'équipe | Alain Hovnanian

Presentation

Alain Hovnanian

Contact

Research: a scientific adventure

Our goal: to better understand genetic diseases to better treat them.

Resources & publications

Publications

J. Exp. Med. 2014

Transgenic kallikrein 5 mice reproduce major cutaneous and systemic hallmarks...
PLoS Genet. 2016

KLK5 Inactivation Reverses Cutaneous Hallmarks of Netherton Syndrome.
J. Invest. Dermatol. 2017

Gene-Corrected Fibroblast Therapy for Recessive Dystrophic Epidermolysis Bull...
J. Invest. Dermatol. 2017

Targeted Exon Skipping Restores Type VII Collagen Expression and Anchoring Fi...
J. Invest. Dermatol. 2017

Selective Substrates and Inhibitors for Kallikrein-Related Peptidase 7 (KLK7)...
J. Am. Acad. Dermatol. 2018

Diacerein orphan drug development for epidermolysis bullosa simplex: A phase ...
J. Invest. Dermatol. 2019

Intradermal Injection of Bone Marrow Mesenchymal Stromal Cells Corrects Reces...
Sci Transl Med 2019

APOBEC mutation drives early-onset squamous cell carcinomas in recessive dyst...
Mol Ther Nucleic Acids 2019

Ex Vivo COL7A1 Correction for Recessive Dystrophic Epidermolysis Bullosa Usin...
J. Invest. Dermatol. 2019

Mutations in PERP Cause Dominant and Recessive Keratoderma.
J. Invest. Dermatol. 2019

Mutations in PERP Cause Dominant and Recessive Keratoderma.
Br. J. Dermatol. 2019

EBGene trial: patient preselection outcomes for the European GENEGRAFT ex viv...
J. Invest. Dermatol. 2019

Mutations in PERP Cause Dominant and Recessive Keratoderma.
J. Invest. Dermatol. 2019

A TP63 mutation causes prominent alopecia with mild ectodermal dysplasia.
J. Invest. Dermatol. 2019

A TP63 mutation causes prominent alopecia with mild ectodermal dysplasia.